CARMAT Stock price

Equities

ALCAR

FR0010907956

Medical Equipment, Supplies & Distribution

Market Closed - Euronext Paris 11:35:22 2024-02-21 am EST After market 03:59:59 pm
4.21 EUR -2.21% Intraday chart for CARMAT 4.225 +0.36%
Sales 2023 * 8.64M 9.35M Sales 2024 * 16.41M 17.74M Capitalization 107M 115M
Net income 2023 * -49M -52.98M Net income 2024 * -33M -35.68M EV / Sales 2023 * 17.5 x
Net Debt 2023 * 44.6M 48.22M Net Debt 2024 * 90.8M 98.17M EV / Sales 2024 * 12 x
P/E ratio 2023 *
-2.01 x
P/E ratio 2024 *
-3.37 x
Employees 177
Yield 2023 *
-
Yield 2024 *
-
Free-Float 66.29%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on CARMAT

1 day+0.23%
1 week+0.35%
Current month+6.54%
1 month+2.25%
3 months+0.23%
6 months-38.62%
Current year-35.60%
More quotes
1 week
4.21
Extreme 4.21
4.50
1 month
3.87
Extreme 3.87
4.64
Current year
3.87
Extreme 3.87
7.72
1 year
3.00
Extreme 3
10.43
3 years
3.00
Extreme 3
33.10
5 years
3.00
Extreme 3
36.00
10 years
3.00
Extreme 3
98.96
More quotes
Managers TitleAgeSince
Chief Executive Officer - 16-08-31
Founder 91 08-06-24
Director of Finance/CFO - 18-12-11
Members of the board TitleAgeSince
Chairman 61 22-12-21
Director/Board Member 85 16-04-11
Director/Board Member 69 18-04-04
More insiders
Date Price Change Volume
24-02-21 4.21 -2.21% 29 053
24-02-20 4.305 -0.23% 46,906
24-02-19 4.315 -1.37% 35,504
24-02-16 4.375 +0.92% 75,634
24-02-15 4.335 +0.81% 14,331

Real-time Euronext Paris, February 21, 2024 at 03:05 am EST

More quotes
CARMAT specializes in the development of a fully implantable orthotopic artificial heart, its electrical power supply system, and its telediagnostics system. The artificial heart is intended for patients with advanced cardiac insufficiency who are ineligible for a transplant and have exhausted all medication alternatives.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
4.305 EUR
Average target price
14.22 EUR
Spread / Average Target
+230.31%
Consensus
  1. Stock
  2. Equities
  3. Stock CARMAT - Euronext Paris
+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019
Replicate our performance
fermer